4 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 57 points (-0.4%) at 13,942 as of Monday, Feb. 25, 2013, 12:05 PM ET. The NYSE advances/declines ratio sits at 1,301 issues advancing vs. 1,576 declining with 144 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Smith & Nephew ( SNN), down 1.2%, and Intuitive Surgical ( ISRG), down 0.4%. Top gainers within the industry include Opko Health ( OPK), up 4.0%, Mindray Medical International ( MR), up 1.9%, Cooper Companies ( COO), up 1.6%, Agilent Technologies ( A), up 0.6% and Baxter International ( BAX), up 0.6%.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today:

4. Fresenius Medical Care Corporation ( FMS) is one of the companies pushing the Health Services industry lower today. As of noon trading, Fresenius Medical Care Corporation is down $0.61 (-1.7%) to $34.40 on average volume Thus far, 122,944 shares of Fresenius Medical Care Corporation exchanged hands as compared to its average daily volume of 274,800 shares. The stock has ranged in price between $34.40-$34.82 after having opened the day at $34.80 as compared to the previous trading day's close of $35.01.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides products and services for the treatment of end-stage renal disease worldwide. The company owns and operates dialysis clinics that provide dialysis treatment, and related laboratory and diagnostic services. Fresenius Medical Care Corporation has a market cap of $10.3 billion and is part of the health care sector. The company has a P/E ratio of 19.4, above the S&P 500 P/E ratio of 17.7. Shares are down 0.3% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Fresenius Medical Care Corporation a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Fresenius Medical Care Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Fresenius Medical Care Corporation Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

3. As of noon trading, Mettler-Toledo International ( MTD) is down $2.26 (-1.1%) to $210.34 on heavy volume Thus far, 241,555 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 153,700 shares. The stock has ranged in price between $210.13-$214.68 after having opened the day at $213.11 as compared to the previous trading day's close of $212.59.

Mettler-Toledo International Inc. supplies precision instruments and services worldwide. Mettler-Toledo International has a market cap of $6.4 billion and is part of the health care sector. The company has a P/E ratio of 23.3, above the S&P 500 P/E ratio of 17.7. Shares are up 10.1% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Mettler-Toledo International a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Mettler-Toledo International Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, CareFusion ( CFN) is down $0.40 (-1.2%) to $32.32 on heavy volume Thus far, 1.1 million shares of CareFusion exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $32.22-$32.93 after having opened the day at $32.89 as compared to the previous trading day's close of $32.72.

CareFusion Corporation provides various healthcare products and services in the United States and internationally. It operates in two segments, Medical Systems and Procedural Solutions. CareFusion has a market cap of $7.2 billion and is part of the health care sector. Shares are up 12.7% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, Tenet Healthcare ( THC) is down $0.70 (-1.8%) to $38.61 on light volume Thus far, 435,267 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $38.61-$39.59 after having opened the day at $39.48 as compared to the previous trading day's close of $39.31.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.2 billion and is part of the health care sector. The company has a P/E ratio of 55.7, above the S&P 500 P/E ratio of 17.7. Shares are up 20.1% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, weak operating cash flow and poor profit margins. Get the full Tenet Healthcare Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Micron Spikes After $10 Billion Buyback Plan Caps Bullish Q3 Earnings Forecast

Micron Spikes After $10 Billion Buyback Plan Caps Bullish Q3 Earnings Forecast

Global Stocks Push Higher as China Tariff Move, Softer US Dollar Boost Sentiment

Global Stocks Push Higher as China Tariff Move, Softer US Dollar Boost Sentiment

Get to Know Stacey Cunningham, the NYSE's First Female Chief in 226 Years

Get to Know Stacey Cunningham, the NYSE's First Female Chief in 226 Years

60 Seconds: What is the Volcker Rule and How Does it Affect Your Portfolio?

60 Seconds: What is the Volcker Rule and How Does it Affect Your Portfolio?

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know